Ed Silverman Pharalot Blog: FDA Begins Crackdown On "Risky" Compounders

In the wake of the scandal over the fungal meningitis outbreak, the FDA last month began a new crackdown on compounding pharmacies that is targeting about 30 so-called ‘high risk’ operations in nearly a dozen states and late last week disclosed that inspections reports were issued for four compounders for a variety of serious manufacturing violations.

continue reading Pharalot blog